Webinar on IWRS | Randomization and kit approach using oomnia RTSM

Critical for ensuring accuracy, compliance, and operational efficiency in clinical trials.
What you’ll learn:
• Fundamentals of randomisation and stratification in clinical trials
• Different types of randomisations: simple, block, stratified, adaptive, and forced
• Comparison of generalised vs. customised kit preparation approaches
• Best practices for kit management and inventory tracking
• Benefits and challenges of the generalised kit approach in real trials

How oomnia RTSM ensures:
• Maintained blinding through neutral kit codes
• Streamlined operations and minimised site errors
• Real-time tracking for compliance and documentation
• Flexible dose titration with fallback kits
• Key technical and stratification learnings

Key Highlights of the case study:
1. Seamlessly managed IP packaging and Blinding through IWRS
2. Supported comprehensive site management activities
3. Successfully helped in recruiting 236 patients in just 18 days
4. Enabled real-time randomisation via our IWRS capabilities
5. Conducted parallel data cleaning, achieving BDL completion in only 4 days
6. Demonstrated capability to efficiently manage large-scale, intricate Phase-III studies

This project showcases Raptim’s proven ability to deliver operational excellence and reliability for your upcoming clinical programs.

We would be delighted to address any questions or discuss how our experience can support your future clinical studies. Write us to: [email protected]

Speakers:
1. Dr Nikola Cihoric, Founder & Chief Product Officer, Wemedoo
2. Dr Dhiraj Patel, Director at Velocious

Moderator:
1. Mr Raj Kumar, Sr. Executive, BD, Raptim Research